Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rollag

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Scandinavian Journal of Infectious Diseases|January 1, 1991
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor poolsH Rollag, G Patou, J R Pattison, et al.
Diabetologia|September 1, 2004
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantationJ Hjelmesaeth, S Sagedal, A Hartmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 28, 2011
Response to letter about intensity of immunosuppressive therapy on outcome of treatment for CMV diseaseA Asberg, A G Jardine, A A Bignamini, et al.
Virus Genes|November 29, 2001
Simian virus 40 large T-antigen, but not small T-antigen, trans-activates the human cytomegalovirus major immediate early promoterU Moens, M Van Ghelue, A K Kristoffersen, et al.
Clinical and Experimental Immunology|November 19, 2013
Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9E Taraldsrud, B Fevang, P Aukrust, et al.
Blood|October 1, 1996
Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitroM Holberg-Petersen, H Rollag, S Beck, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 30, 1991
[Allogeneic bone marrow transplantation in adults. Results after fractionated whole body irradiation and high dosage cyclophosphamide and use of HLA-compatible sibling donors]L Brinch, S A Evensen, D Albrechtsen, et al.
Blood|December 15, 1996
Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cellsH Sindre, G E Tjøonnfjord, H Rollag, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2010
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipientsA Asberg, A G Jardine, A A Bignamini, et al.
Transplantation|November 4, 2000
A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipientsS Sagedal, K P Nordal, A Hartmann, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Scandinavian Journal of Infectious Diseases|January 1, 1991
Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor poolsH Rollag, G Patou, J R Pattison, et al.
Diabetologia|September 1, 2004
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantationJ Hjelmesaeth, S Sagedal, A Hartmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 28, 2011
Response to letter about intensity of immunosuppressive therapy on outcome of treatment for CMV diseaseA Asberg, A G Jardine, A A Bignamini, et al.
Virus Genes|November 29, 2001
Simian virus 40 large T-antigen, but not small T-antigen, trans-activates the human cytomegalovirus major immediate early promoterU Moens, M Van Ghelue, A K Kristoffersen, et al.
Clinical and Experimental Immunology|November 19, 2013
Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9E Taraldsrud, B Fevang, P Aukrust, et al.
Blood|October 1, 1996
Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitroM Holberg-Petersen, H Rollag, S Beck, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 30, 1991
[Allogeneic bone marrow transplantation in adults. Results after fractionated whole body irradiation and high dosage cyclophosphamide and use of HLA-compatible sibling donors]L Brinch, S A Evensen, D Albrechtsen, et al.
Blood|December 15, 1996
Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cellsH Sindre, G E Tjøonnfjord, H Rollag, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 22, 2010
Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipientsA Asberg, A G Jardine, A A Bignamini, et al.
Transplantation|November 4, 2000
A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipientsS Sagedal, K P Nordal, A Hartmann, et al.
Pageof 11